26 min listen
Avedro CEO Muller Answers Questions about the FDA’s Questions
Avedro CEO Muller Answers Questions about the FDA’s Questions
ratings:
Length:
20 minutes
Released:
May 12, 2015
Format:
Podcast episode
Description
David Muller, CEO of Avedro, addresses delays in the FDA’s review of the company’s riboflavin ophthalmic solution/KXL System for corneal cross-linking and discusses the considerable potential of PIXL.
Released:
May 12, 2015
Format:
Podcast episode
Titles in the series (100)
Mazzo Muses on the FDA, Google and Failing Fast by OIS Podcast | Ophthalmology's leading Podcast